H2 injection aids diabetes outcomes in animal model

H<sub>2</sub> injection aids diabetes outcomes in animal model
(HealthDay)—Subcutaneous injection of H2 significantly improves type 2 diabetes mellitus (T2DM)-related outcomes in a mouse model, according to a study published online April 8 in the Journal of Diabetes Investigation.

Xiaolong Zhang, from the Second Affiliated Hospital of Wenzhou Medical University in China, and colleagues evaluated whether subcutaneous injection of H2 (1 mL/mouse/week for four weeks) shows enhanced efficacy against T2DM induced in mice by a high-fat diet and low-dose streptozotocin treatment.

The researchers found that the body weight of H2-treated mice did not change over the study period. Glucose, insulin, low-density lipoprotein, and triglyceride levels in serum were significantly lower in treated mice versus untreated controls, while high-density lipoprotein cholesterol in the serum was significantly higher. In H2-treated , both and insulin sensitivity were improved. H2 treatment also lead to significant reductions in urine volume, urinary total protein and β2 microglobulin, kidney/body weight ratio, and kidney fibrosis, in diabetic nephropathy analysis.

"Subcutaneous injection of H2 significantly improves T2DM and diabetic nephropathy related outcomes in a , supporting further consideration of subcutaneous as a novel and effective route of clinical H2 administration," the authors write.

Explore further

Continuous subcutaneous insulin infusion bests injections in T2DM

More information: Abstract
Full Text

Copyright © 2017 HealthDay. All rights reserved.

Citation: H2 injection aids diabetes outcomes in animal model (2017, May 3) retrieved 24 April 2019 from https://medicalxpress.com/news/2017-05-h2-aids-diabetes-outcomes-animal.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more